Clinical Trials Browser

Terminated × Fatty Acids, Omega-3 × Clear all

NCT04006847 2022-07-01

Omega -3 Fatty Acid in Combination With Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

Phase 1/2 Terminated

1 enrolled 5 charts

Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase

NCT02795572 2019-07-05

CIPN

Phase 2 Terminated

Breast Neoplasms, Peripheral Nervous System Diseases

NCT00458549 2018-07-13

Polyunsaturated Fatty Acids in Treating Patients With Prostate Cancer Undergoing Prostate Biopsy and/or Surgery

Phase NA Terminated

Prostatic Neoplasms

NCT01803711 2017-12-27

Omega 3 FA Supplements as Augmentation in the Treatment of Depression

Phase 2/3 Terminated

6 enrolled 4 charts

Cardiovascular Diseases, Depression, Depressive Disorder, Major, Diabetes Mellitus, Hypertension, Neoplasms

NCT00930527 2014-07-23

Omega-3-Fatty Acid on Joint Symptoms Inducted by Aromatase Inhibitors

Phase 2 Terminated

Breast Neoplasms

NCT00899353 2013-12-12

Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM)

Phase 2 Terminated

16 enrolled 6 charts

LymphoidOther hematologic neoplasmPlasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Leukemia, Lymphocytic, Chronic, B-Cell